Cripto-1 as a novel therapeutic target for triple negative breast cancer.

DISCUSSION Pre-clinical animal models that can recapitulate the metastatic process and resemble specific molecular subtypes of human BC as well as facilitate identification and validation of candidate drug target genes are greatly desired since gene expression patterns in the mouse models shows extraordinarily significant correlations with those of the human conditions [ 38 ].

also in 43 other papers